title: [A hybrid molecule of pro-urokinase and a fibrin-specific, monoclonal antibody fragment is a more effective thrombolytic agent than pro-urokinase in vitro and in vivo].
authors: Medizinische Klinik III, Universität Heidelberg.
authors: C
authors: C
authors: Bode
authors: T
authors: T
authors: Eberle
authors: M
authors: M
authors: Runge
authors: E
authors: E
authors: Haber
authors: W
authors: W
authors: Kübler
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology*; D000918:Antibody Specificity / Q000276:immunology; D005337:Fibrin / Q000276:immunology*; D005342:Fibrinolysis / Q000187:drug effects / Q000276:immunology; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D010960:Plasminogen Activators / Q000494:pharmacology*; D011817:Rabbits; D013927:Thrombosis / Q000097:blood*; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology*
chemical_list: D000911:Antibodies, Monoclonal; D005343:Fibrinolytic Agents; D005337:Fibrin; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator
vernacular_title: Ein Hybridmolekül aus Prourokinase und einem fibrinspezifischen, monoklonalen Antikörperfragment ist thrombolytisch wirksamer als Prourokinase in vitro und in vivo.